NCT01891981 2023-10-13Study of Moxetumomab Pasudotox in Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia (ALL)M.D. Anderson Cancer CenterPhase 1 Terminated16 enrolled
NCT00587457 2017-07-06A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic LeukemiaMedImmune LLCPhase 1 Terminated11 enrolled 14 charts